Copyright Reports & Markets. All rights reserved.

Global Parkinsons Disease Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Parkinsons Disease Drugs Market Overview

      • 1.1 Product Overview and Scope of Parkinsons Disease Drugs
      • 1.2 Parkinsons Disease Drugs Segment by Type
        • 1.2.1 Global Parkinsons Disease Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Clinical
        • 1.2.3 Experiment
      • 1.3 Parkinsons Disease Drugs Segment by Application
        • 1.3.1 Parkinsons Disease Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Treament
        • 1.3.3 Prevention
      • 1.4 Global Parkinsons Disease Drugs Market by Region
        • 1.4.1 Global Parkinsons Disease Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Parkinsons Disease Drugs Market Size
        • 1.5.1 Global Parkinsons Disease Drugs Revenue (2014-2025)
        • 1.5.2 Global Parkinsons Disease Drugs Production (2014-2025)

      2 Global Parkinsons Disease Drugs Market Competition by Manufacturers

      • 2.1 Global Parkinsons Disease Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Parkinsons Disease Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Parkinsons Disease Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Parkinsons Disease Drugs Production Sites, Area Served, Product Types
      • 2.5 Parkinsons Disease Drugs Market Competitive Situation and Trends
        • 2.5.1 Parkinsons Disease Drugs Market Concentration Rate
        • 2.5.2 Parkinsons Disease Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Parkinsons Disease Drugs Production Market Share by Regions

      • 3.1 Global Parkinsons Disease Drugs Production Market Share by Regions
      • 3.2 Global Parkinsons Disease Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Parkinsons Disease Drugs Production
        • 3.4.1 North America Parkinsons Disease Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Parkinsons Disease Drugs Production
        • 3.5.1 Europe Parkinsons Disease Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Parkinsons Disease Drugs Production (2014-2019)
        • 3.6.1 China Parkinsons Disease Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Parkinsons Disease Drugs Production (2014-2019)
        • 3.7.1 Japan Parkinsons Disease Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Parkinsons Disease Drugs Consumption by Regions

      • 4.1 Global Parkinsons Disease Drugs Consumption by Regions
      • 4.2 North America Parkinsons Disease Drugs Consumption (2014-2019)
      • 4.3 Europe Parkinsons Disease Drugs Consumption (2014-2019)
      • 4.4 China Parkinsons Disease Drugs Consumption (2014-2019)
      • 4.5 Japan Parkinsons Disease Drugs Consumption (2014-2019)

      5 Global Parkinsons Disease Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Parkinsons Disease Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Parkinsons Disease Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Parkinsons Disease Drugs Price by Type (2014-2019)
      • 5.4 Global Parkinsons Disease Drugs Production Growth by Type (2014-2019)

      6 Global Parkinsons Disease Drugs Market Analysis by Applications

      • 6.1 Global Parkinsons Disease Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Parkinsons Disease Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Parkinsons Disease Drugs Business

      • 7.1 Johnson & Johnson
        • 7.1.1 Johnson & Johnson Parkinsons Disease Drugs Production Sites and Area Served
        • 7.1.2 Parkinsons Disease Drugs Product Introduction, Application and Specification
        • 7.1.3 Johnson & Johnson Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Gilead Sciences
        • 7.2.1 Gilead Sciences Parkinsons Disease Drugs Production Sites and Area Served
        • 7.2.2 Parkinsons Disease Drugs Product Introduction, Application and Specification
        • 7.2.3 Gilead Sciences Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Pacira
        • 7.3.1 Pacira Parkinsons Disease Drugs Production Sites and Area Served
        • 7.3.2 Parkinsons Disease Drugs Product Introduction, Application and Specification
        • 7.3.3 Pacira Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Sun Pharmaceutical
        • 7.4.1 Sun Pharmaceutical Parkinsons Disease Drugs Production Sites and Area Served
        • 7.4.2 Parkinsons Disease Drugs Product Introduction, Application and Specification
        • 7.4.3 Sun Pharmaceutical Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Luye Pharma
        • 7.5.1 Luye Pharma Parkinsons Disease Drugs Production Sites and Area Served
        • 7.5.2 Parkinsons Disease Drugs Product Introduction, Application and Specification
        • 7.5.3 Luye Pharma Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Sigma-Tau Group
        • 7.6.1 Sigma-Tau Group Parkinsons Disease Drugs Production Sites and Area Served
        • 7.6.2 Parkinsons Disease Drugs Product Introduction, Application and Specification
        • 7.6.3 Sigma-Tau Group Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Fudan-Zhangjiang
        • 7.7.1 Fudan-Zhangjiang Parkinsons Disease Drugs Production Sites and Area Served
        • 7.7.2 Parkinsons Disease Drugs Product Introduction, Application and Specification
        • 7.7.3 Fudan-Zhangjiang Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Teva Pharmaceutical
        • 7.8.1 Teva Pharmaceutical Parkinsons Disease Drugs Production Sites and Area Served
        • 7.8.2 Parkinsons Disease Drugs Product Introduction, Application and Specification
        • 7.8.3 Teva Pharmaceutical Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 CSPC
        • 7.9.1 CSPC Parkinsons Disease Drugs Production Sites and Area Served
        • 7.9.2 Parkinsons Disease Drugs Product Introduction, Application and Specification
        • 7.9.3 CSPC Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Novartis
        • 7.10.1 Novartis Parkinsons Disease Drugs Production Sites and Area Served
        • 7.10.2 Parkinsons Disease Drugs Product Introduction, Application and Specification
        • 7.10.3 Novartis Parkinsons Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Kingond Pharm

      8 Parkinsons Disease Drugs Manufacturing Cost Analysis

      • 8.1 Parkinsons Disease Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Parkinsons Disease Drugs
      • 8.4 Parkinsons Disease Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Parkinsons Disease Drugs Distributors List
      • 9.3 Parkinsons Disease Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Parkinsons Disease Drugs Market Forecast

      • 11.1 Global Parkinsons Disease Drugs Production, Revenue Forecast
        • 11.1.1 Global Parkinsons Disease Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Parkinsons Disease Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Parkinsons Disease Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Parkinsons Disease Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Parkinsons Disease Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Parkinsons Disease Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Parkinsons Disease Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Parkinsons Disease Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Parkinsons Disease Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Parkinsons Disease Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Parkinsons Disease Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Parkinsons Disease Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Parkinsons Disease Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Parkinsons Disease Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Parkinsons Disease Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.The symptoms generally come on slowly over time.Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking.Thinking and behavioral problems may also occur.Dementia becomes common in the advanced stages of the disease.Depression and anxiety are also common, occurring in more than a third of people with PD.Other symptoms include sensory, sleep, and emotional problems.The main motor symptoms are collectively called "parkinsonism", or a "parkinsonian syndrome"
        The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
        This report analyzes the worldwide markets for Parkinsons Disease Drugs in US$ by following Product Segments.: Clinical, Experiment
        Company profiles are primarily based on public domain information including company
        Johnson & Johnson
        Gilead Sciences
        Pacira
        Sun Pharmaceutical
        Luye Pharma
        Sigma-Tau Group
        Fudan-Zhangjiang
        Teva Pharmaceutical
        CSPC
        Novartis
        Kingond Pharm

        The global Parkinsons Disease Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Parkinsons Disease Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinsons Disease Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Johnson & Johnson
        Gilead Sciences
        Pacira
        Sun Pharmaceutical
        Luye Pharma
        Sigma-Tau Group
        Fudan-Zhangjiang
        Teva Pharmaceutical
        CSPC
        Novartis
        Kingond Pharm

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Clinical
        Experiment

        Segment by Application
        Treament
        Prevention

        Buy now